HIF-1-modified BMSCs improve migration and reduce neuronal apoptosis after stroke in rats

6Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Bone marrow-derived mesenchymal stem cells (BMSCs) have been demonstrated ameliorating neurologic deficits after stroke. Hypoxia-inducible factor-1 (HIF-1), the key regulator of cellular responses to low oxygen concentration, can activate multiple genes involving in crucial aspects for neurologic recovery. In this study, we present that rat BMSCs overexpression of HIF-1 α showed higher expression of HIF-1 target genes in HIF-1-BMSCs, including CXCR4, EPO, and VEGF. BMSCs-mHIF-1α also exhibited an enhanced mobility towards the ischemic area within rat brain. Neural cell apoptosis in ischemic brain shown less severe in rats transplanted with HIF-1-BMSCs. Furthermore, the number of cells expressing neural progenitor markers PAX6 and DCX were increased in BMSCs-mHIF-1α-transplanted rats. These results suggest that HIF-1α in BMSCs reduces neuronal apoptosis and promotes neurogenesis after stroke in rats. © 2013 The Author(s).

Cite

CITATION STYLE

APA

Ye, Z. Z., Ye, W. B., Deng, Y. B., Wang, J., Zhou, G. Q., & Zhang, X. Q. (2013). HIF-1-modified BMSCs improve migration and reduce neuronal apoptosis after stroke in rats. Chinese Science Bulletin, 58(28–29), 3519–3528. https://doi.org/10.1007/s11434-013-5936-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free